Lumos Pharma Inc.
(LUMO)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST
Company Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases.
Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders.
The company is headquartered in Austin, Texas.
Lumos Pharma Inc.
| Country | United States |
| IPO Date | Nov 11, 2011 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 30 |
| CEO | Richard J. Hawkins |
Contact Details
Address: 4200 Marathon Boulevard Austin, Texas United States | |
| Website | https://www.lumos-pharma.com |
Stock Details
| Ticker Symbol | LUMO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001126234 |
| CUSIP Number | 55028X109 |
| ISIN Number | US55028X1090 |
| Employer ID | 42-1491350 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Richard J. Hawkins | Founder, Chief Executive Officer & Chairman |
| Lori D. Lawley CPA | Chief Financial Officer & Principal Accounting Officer |
| Aaron Schuchart B.B.A., CPA, M.B.A. | Chief Business Officer |
| Alpa Parikh | Senior Vice President of CMC & Supply Management |
| Bradley J. Powers J.D. | Chief Compliance Officer & General Counsel |
| Dr. John C. McKew Ph.D. | Chief Scientific Officer & President |
| Dr. Pisit Pitukcheewanont FAAP, M.D. | Chief Medical Officer |
| Eddie L. Varnado M.B.A. | Corporate Controller |
| Lisa Wells Miller | Senior Director of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 13, 2024 | AW | Filing |
| Dec 12, 2024 | POS AM | Filing |
| Dec 12, 2024 | POS AM | Filing |
| Dec 12, 2024 | POS AM | Filing |
| Dec 12, 2024 | POS AM | Filing |
| Dec 12, 2024 | POS AM | Filing |
| Dec 12, 2024 | POS AM | Filing |
| Dec 12, 2024 | S-8 POS | Filing |
| Dec 12, 2024 | S-8 POS | Filing |
| Dec 12, 2024 | S-8 POS | Filing |